ZIMURA Trademark Information

Trademark by IVERIC bio, Inc.

Pharmaceutical preparations for treating Age-Related Macular Degeneration (AMD)

Research and development of new products and pharmaceutical preparations in the field of medicine; scientific, medical and pharmaceutical research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals; scientific investigations for medical purposes

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ZIMURA
Status/Status Date:
NEW APPLICATION FILED
10/21/2021
Serial Number: 97080150
Filing Date: 10/18/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for treating Age-Related Macular Degeneration (AMD)
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
IVERIC bio, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NEW APPLICATION FILED
10/21/2021
Correspondent Search:
BEN NATTER is a correspondent of ZIMURA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on